Advanced Stage Intrahepatic Biliary Tract Cancer Btc clinical trials

Explore recruiting advanced stage intrahepatic biliary tract cancer btc clinical trials.

Recruiting advanced stage intrahepatic biliary tract cancer btc studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Stage Intrahepatic Biliary Tract Cancer Btc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

IMMUWHY - A phase II study of immunotherapy with durvalumab (MEDI4736) or durvalumab and tremelimumab, both combined with Y-90 SIRT therapy in patients with advanced stage intrahepatic biliary tract cancer (BTC) scheduled to receive Y-90 SIRT therapy as standard of care

Germany, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Advanced Stage Intrahepatic Biliary Tract Cancer Btc trials by city

Advanced Stage Intrahepatic Biliary Tract Cancer Btc clinical trials

Recruiting advanced stage intrahepatic biliary tract cancer btc studies right now

Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

Also recruiting in Europe

IMMUWHY - A phase II study of immunotherapy with durvalumab (MEDI4736) or durvalumab and tremelimumab, both combined with Y-90 SIRT therapy in patients with advanced stage intrahepatic biliary tract cancer (BTC) scheduled to receive Y-90 SIRT therapy as standard of care

Advanced Stage Intrahepatic Biliary Tract Cancer Btc trials by city

Other conditions